Peptichemio, vincristine and prednisone versus melphalan and prednisone as induction therapy in multiple myeloma

This publication has 19 references indexed in Scilit:

• A randomized trial of melphalan and prednisone versus melphalan, prednisone, cyclophosphamide, MeCCNU, and vincristine in untreated multiple myeloma.
  Journal of Clinical Oncology, 1984
• Comparison of two long-term chemotherapy regimens, with or without agents to modify skeletal repair, in multiple myeloma
  Blood, 1984
• Progress in the treatment of plasma cell myeloma?
  Journal of Clinical Oncology, 1983
• A new improved clinical staging system for multiple myeloma based on analysis of 123 treated patients
  Blood, 1980
• The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia
  New England Journal of Medicine, 1979
• Improved survival of increased-risk myeloma patients on combined triple- alkylating-agent therapy: a study of the CALGB
  Blood, 1979
• Cytokinetic changes in two cases of plasma cell leukemia treated with a multipeptide derivative of m-[di(2-chloroethyl)amino]-l-phenylalanine (Peptichemio)
  Published by Elsevier ,1978
• Melphalan and prednisone: An effective combination for the treatment of multiple myeloma
  The American Journal of Medicine, 1973
• A computer program for comparing K samples with right-censored data
  Computer Programs in Biomedicine, 1972
• Evaluating differences in survival between two groups of patients
  Journal of Chronic Diseases, 1971